AREV Life Sciences Global Corp. (AREV.CN) Research

AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005, operates as an integrated life science discovery firm, focusing on the development and sale of functional ingredients throughout Canada. Its diverse product line includes various CBD-infused items like the anti-viral supplements Canna-Mulsion and NaturVax, NaturRelax for natural sleep support, and Natur Relief, designed for anti-inflammatory and pain relief. Additionally, the company provides white-label cannabis products, a selection of THC offerings, cannabis-based skincare, and medicinal oils and edibles. These specialized ingredients are utilized in products intended for the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical industries. AREV's solutions target health concerns such as sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, alongside other specific ailments. The company also offers nutraceutical formulations under its Bare brand and ready-to-use therapeutic food products named SUS-TAINN. Formerly known as AREV NanoTec Brands Inc., the company officially adopted its current name in August 2021.

Market snapshot

Symbol
AREV.CN
Price
$0.09
Day change
0.00%
Market cap
$2.8M
P/E ratio
-1.87x
52-week range
0.09-0.09
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aion Therapeutic Inc. (AION.CN)
  • Acerus Pharmaceuticals Corporation (ASP.TO)
  • Craftport Cannabis Corp. (CFT.CN)
  • Choom Holdings Inc. (CHOO.CN)
  • Flower One Holdings Inc. (FONE.CN)
  • Isracann Biosciences Inc. (IPOT.CN)
  • ManifestSeven Holdings Corporation (MSVN.CN)
  • North Bud Farms Inc. (NBUD.CN)

Open AREV Life Sciences Global Corp. (AREV.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.